Europe's most valuable company wants to make Denmark quantum hub
Novo Holdings, the parent company of the creator of ‘miracle drug’ Ozempic, Novo Nordisk, already spends $1–2bn a year investing in and building healthtech startups. Now the Danish company is betting on a new tech sector: it’s earmarked DKK 1.4bn (€188m) …